HER2POSITIVE

Clinical trials for HER2POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2POSITIVE trials appear

Sign up with your email to follow new studies for HER2POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug delivery methods tested for tough breast cancer

Disease control Not yet recruiting

This study tests a drug called SHR-A1811 in 60 people with HER2-positive advanced breast cancer. Researchers want to see if giving the drug in different ways (like injection or infusion) works better and is safe. The goal is to shrink tumors or stop them from growing, but this is…

Matched conditions: HER2POSITIVE

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 09, 2026 05:35 UTC

HER2POSITIVE

Get alerted when new HER2POSITIVE trials appear

New drug delivery methods tested for tough breast cancer